Gardnerella vaginalis promotes group B Streptococcus vaginal colonization, enabling ascending uteroplacental infection in pregnant mice.
Animals
Coinfection
/ complications
Cytokines
/ metabolism
Dysbiosis
/ microbiology
Female
Gardnerella vaginalis
Mice
Microbial Interactions
Microbiota
Placenta
/ microbiology
Placenta Diseases
/ metabolism
Pregnancy
Streptococcal Infections
/ microbiology
Streptococcus agalactiae
Uterine Diseases
/ microbiology
Vagina
/ microbiology
Vaginosis, Bacterial
/ microbiology
Gardnerella vaginalis
ascending infection
bacterial vaginosis
group B Streptococcus
health disparities
microbiota
placenta
uterus
vagina
vaginal microbiome
Journal
American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
29
04
2020
revised:
16
11
2020
accepted:
18
11
2020
pubmed:
29
11
2020
medline:
8
6
2021
entrez:
28
11
2020
Statut:
ppublish
Résumé
Group B Streptococcus is a common vaginal bacterium and the leading cause of invasive fetoplacental infections. Group B Streptococcus in the vagina can invade through the cervix to cause ascending uteroplacental infections or can be transmitted to the neonate during vaginal delivery. Some studies have found that women with a "dysbiotic" polymicrobial or Lactobacillus-depleted vaginal microbiota are more likely to harbor group B Streptococcus. Gardnerella vaginalis is often the most abundant bacteria in the vaginas of women with dysbiosis, while being detected at lower levels in most other women, and has been linked with several adverse pregnancy outcomes. Mouse models of group B Streptococcus and Gardnerella vaginalis colonization have been reported but, to the best of our knowledge, the two have not been studied together. The overarching idea driving this study is that certain members of the dysbiotic vaginal microbiota, such as Gardnerella vaginalis, may directly contribute to the increased rate of group B Streptococcus vaginal colonization observed in women with vaginal dysbiosis. We used a mouse model to test the hypothesis that vaginal exposure to Gardnerella vaginalis may facilitate colonization and/or invasive infection of the upper reproductive tract by group B Streptococcus during pregnancy. Timed-pregnant mice were generated using an allogeneic mating strategy with BALB/c males and C57Bl/6 females. Dams were vaginally inoculated at gestational day 14 with group B Streptococcus alone (using a 10-fold lower dose than previously reported models) or coinoculated with group B Streptococcus and Gardnerella vaginalis. Bacterial titers were enumerated in vaginal, uterine horn, and placental tissues at gestational day 17. The presence (Fisher exact tests) and levels (Mann-Whitney U tests) of bacterial titers were compared between mono- and coinoculated dams in each compartment. Relative risks were calculated for outcomes that occurred in both groups. Tissue samples were also examined for evidence of pathophysiology. Inoculation of pregnant mice with 10 These data suggest that Gardnerella vaginalis vaginal exposure can promote group B Streptococcus vaginal colonization, resulting in a greater likelihood of invasive perinatal group B Streptococcus infections. These findings suggest that future clinical studies should examine whether the presence of Gardnerella vaginalis is a risk factor for group B Streptococcus vaginal colonization in women. Because Gardnerella vaginalis can also be present in women without bacterial vaginosis, these findings may be relevant both inside and outside of the context of vaginal dysbiosis.
Sections du résumé
BACKGROUND
Group B Streptococcus is a common vaginal bacterium and the leading cause of invasive fetoplacental infections. Group B Streptococcus in the vagina can invade through the cervix to cause ascending uteroplacental infections or can be transmitted to the neonate during vaginal delivery. Some studies have found that women with a "dysbiotic" polymicrobial or Lactobacillus-depleted vaginal microbiota are more likely to harbor group B Streptococcus. Gardnerella vaginalis is often the most abundant bacteria in the vaginas of women with dysbiosis, while being detected at lower levels in most other women, and has been linked with several adverse pregnancy outcomes. Mouse models of group B Streptococcus and Gardnerella vaginalis colonization have been reported but, to the best of our knowledge, the two have not been studied together. The overarching idea driving this study is that certain members of the dysbiotic vaginal microbiota, such as Gardnerella vaginalis, may directly contribute to the increased rate of group B Streptococcus vaginal colonization observed in women with vaginal dysbiosis.
OBJECTIVE
We used a mouse model to test the hypothesis that vaginal exposure to Gardnerella vaginalis may facilitate colonization and/or invasive infection of the upper reproductive tract by group B Streptococcus during pregnancy.
STUDY DESIGN
Timed-pregnant mice were generated using an allogeneic mating strategy with BALB/c males and C57Bl/6 females. Dams were vaginally inoculated at gestational day 14 with group B Streptococcus alone (using a 10-fold lower dose than previously reported models) or coinoculated with group B Streptococcus and Gardnerella vaginalis. Bacterial titers were enumerated in vaginal, uterine horn, and placental tissues at gestational day 17. The presence (Fisher exact tests) and levels (Mann-Whitney U tests) of bacterial titers were compared between mono- and coinoculated dams in each compartment. Relative risks were calculated for outcomes that occurred in both groups. Tissue samples were also examined for evidence of pathophysiology.
RESULTS
Inoculation of pregnant mice with 10
CONCLUSION
These data suggest that Gardnerella vaginalis vaginal exposure can promote group B Streptococcus vaginal colonization, resulting in a greater likelihood of invasive perinatal group B Streptococcus infections. These findings suggest that future clinical studies should examine whether the presence of Gardnerella vaginalis is a risk factor for group B Streptococcus vaginal colonization in women. Because Gardnerella vaginalis can also be present in women without bacterial vaginosis, these findings may be relevant both inside and outside of the context of vaginal dysbiosis.
Identifiants
pubmed: 33248136
pii: S0002-9378(20)31331-4
doi: 10.1016/j.ajog.2020.11.032
pmc: PMC8555936
mid: NIHMS1747269
pii:
doi:
Substances chimiques
Cytokines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
530.e1-530.e17Subventions
Organisme : NIAID NIH HHS
ID : R01 AI114635
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD091218
Pays : United States
Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Références
BMC Microbiol. 2018 Nov 26;18(1):197
pubmed: 30477439
J Clin Invest. 2018 May 1;128(5):1985-1999
pubmed: 29629904
Sex Transm Dis. 2010 Dec;37(12):732-44
pubmed: 21068695
mBio. 2016 Jun 28;7(3):
pubmed: 27353757
Am J Obstet Gynecol. 1996 Apr;174(4):1354-60
pubmed: 8623869
PLoS One. 2013;8(3):e59539
pubmed: 23527214
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S160-S172
pubmed: 29117326
J Infect Dis. 2019 Aug 30;220(7):1099-1108
pubmed: 30715405
J Perinat Med. 2009;37(2):130-4
pubmed: 18999913
J Infect Dis. 2017 Sep 15;216(6):744-751
pubmed: 28934437
J Infect Dis. 2014 Aug 1;210(3):338-43
pubmed: 24511102
Cell Host Microbe. 2011 Jul 21;10(1):54-64
pubmed: 21767812
J Biol Chem. 2013 Apr 26;288(17):12067-79
pubmed: 23479734
Nat Commun. 2020 Jan 10;11(1):199
pubmed: 31924800
Am J Obstet Gynecol. 1981 Sep 15;141(2):184-6
pubmed: 7025636
Clin Infect Dis. 2019 Oct 30;69(10):1740-1748
pubmed: 30946447
Paediatr Child Health. 1999 Oct;4(7):465-9
pubmed: 20212961
J Perinatol. 2017 Feb;37(2):157-161
pubmed: 27853322
Sex Transm Dis. 2013 Sep;40(9):721-3
pubmed: 23945426
J Infect Dis. 1988 Jan;157(1):91-100
pubmed: 3275727
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S112-S124
pubmed: 29117328
Obstet Gynecol. 2005 Dec;106(6):1246-52
pubmed: 16319248
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S125-S132
pubmed: 29117322
J Perinatol. 2019 Mar;39(3):433-438
pubmed: 30635596
Am J Epidemiol. 2002 May 15;155(10):949-57
pubmed: 11994235
Sci Rep. 2018 Feb 7;8(1):2593
pubmed: 29416049
Sex Transm Dis. 2007 Nov;34(11):864-9
pubmed: 17621244
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S133-S142
pubmed: 29117329
J Perinatol. 2018 Oct;38(10):1309-1317
pubmed: 30068969
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S100-S111
pubmed: 29117327
Pediatr Infect Dis J. 2011 Nov;30(11):937-41
pubmed: 21654548
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
PLoS One. 2018 Jan 18;13(1):e0191524
pubmed: 29346438
Nat Commun. 2018 Aug 7;9(1):3138
pubmed: 30087335
J Matern Fetal Neonatal Med. 2016 Nov;29(22):3646-51
pubmed: 26795404
Matern Child Health J. 2009 Jul;13(4):512-9
pubmed: 18543090
Am J Obstet Gynecol. 2009 Jul;201(1):76.e1-7
pubmed: 19371857
Obstet Gynecol. 2007 Jan;109(1):114-20
pubmed: 17197596
Obstet Gynecol. 1996 Oct;88(4 Pt 1):577-82
pubmed: 8841222
Am J Obstet Gynecol. 2001 Feb;184(3):427-33
pubmed: 11228498
Neonatology. 2015;108(3):157-63
pubmed: 26182960
Front Cell Infect Microbiol. 2017 Feb 03;7:19
pubmed: 28217556
JAMA Pediatr. 2019 Mar 1;173(3):224-233
pubmed: 30640366
J Infect Dis. 2014 Jul 15;210(2):265-73
pubmed: 24474814
J Infect Chemother. 2002 Dec;8(4):326-30
pubmed: 12525892
J Natl Med Assoc. 2003 Mar;95(3):201-12
pubmed: 12749680
Clin Microbiol Infect. 2017 Dec;23(12):974-979
pubmed: 28478240
PeerJ. 2019 Aug 16;7:e7474
pubmed: 31440433
PLoS Pathog. 2017 Mar 30;13(3):e1006238
pubmed: 28358889
Sex Transm Dis. 2019 May;46(5):304-311
pubmed: 30624309
Am J Obstet Gynecol. 1995 Oct;173(4):1231-5
pubmed: 7485327
Microbiology (Reading). 2014 Oct;160(Pt 10):2272-2282
pubmed: 25073854